Search Results
Diving Into the Potential of Monoclonal Antibodies for Alzheimer Disease Treatment
Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
Lecanemab: A Potential New Drug For Alzheimer's disease
An Update on Anti-Amyloid Treatments for Alzheimer's Disease
ADVANCE Alzheimer’s: A Dive into Diagnosis & Management Webinar | 06 July 2022
Updates in pharmacological treatment of Alzheimer’s disease: lecanemab, donanemab and gantenerumab
Immunotherapies for Alzheimers Disease | 2nd Dubai Neurology Congress
Phase III AHEAD 3-45 trial of lecanemab for preclinical Alzheimer’s disease
Lecanemab for the treatment of early Alzheimer’s disease: the story so far
Exploring Dementia: Can it be Cured? Unveiling Potential Treatments and Hopeful Insights.
Future of Alzheimer's disease
E175 - The PsychopharmaStahlogy Show: Alzheimer’s Disease: Biomarkers and Treatments that Target ...